$ Value
$239K
Shares
6,316
Price
$38
Filed
Mar 4
Insider
Name
Berry Lance A
Title
EVP, COO, CFO & Treasurer
CIK
0001478716
Roles
Transaction Details
Transaction Date
2026-03-03
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
210,827
Footnotes
Represents performance stock units granted on February 28, 2025. One third (1/3) were issued on March 2, 2026. The remaining shares earned in connection with the February 2025 grant will be eligible to vest and be issued as follows: one third (1/3) on February 28, 2027; and one third (1/3) on February 28, 2028, assuming employment on the relevant vesting date. | These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
Filing Info
Berry Lance A's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-03 | AORT | ▼ | $239K |
| 2026-03-02 | AORT | ▼ | $197K |
| 2026-03-02 | AORT | A | $0 |
| 2026-02-24 | AORT | ▼ | $160K |
| 2026-02-24 | AORT | A | $0 |
| 2026-02-23 | AORT | ▼ | $187K |
| 2025-05-20 | TMCI | A | $0 |
Other Insiders at AORT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Horton Amy
VP, Chief Accounting Officer
|
— | $153K | 2026-03-03 |
|
Mackin James P
President & CEO
|
— | $2.5M | 2026-03-03 |
|
Berry Lance A
EVP, COO, CFO & Treasurer
|
— | $544K | 2026-03-02 |
|
Holloway Jean F
SVP, General Counsel
|
— | $744K | 2026-03-04 |
|
Davis John E
Chief Commercial Officer
|
— | $494K | 2026-03-03 |
|
Stanton Marshall S.
SVP, Clinical & MD Affair
|
— | $275K | 2026-03-03 |